Evidence map›Paper›PMID 30568125›Full record

ArticleInternal medicine (Tokyo, Japan)2019

The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation.

Nagisa Morikawa, Takaharu Nakayoshi, Hanae Yoshimura, Megumi Watanabe, Jun Kumanomido, Aya Furusho, Daisuke Fukui, Kazuko Eto, Norifumi Nishida, Michihide Nishihara and 2 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nagisa MorikawaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Takaharu NakayoshiDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Hanae YoshimuraDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Megumi WatanabeDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Jun KumanomidoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Aya FurushoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Daisuke FukuiDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Kazuko EtoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Norifumi NishidaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Michihide NishiharaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Chizuko A KamiyaDepartment of Perinatology and Gynecology, National Cerebral and Cardiovascular Center, Japan.
Yoshihiro FukumotoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.
Kurume University · JPNational Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripartum cardiomyopathy (PPCM) is rare but life-threatening. We herein report the case of a 48-year-old woman with PPCM after oocyte donation and delivery of twins. Two weeks after delivery, she suffered from severe symptoms of heart failure [orthopnea, New York Heart Association (NYHA) class IV, pulmonary edema and a reduced left ventricular ejection fraction of 18%]. Although standard heart failure therapy was effective for diminishing the congestion, it was not sufficient to improve her symptoms or left ventricular systolic dysfunction. During admission, we added bromocriptine. A year later after the onset, she was in a good state with an improved left ventricular systolic function.

Indexed as

BromocriptineCardiomyopathiesFemaleHumansMiddle AgedOocyte DonationPeripartum PeriodPregnancyPregnancy Complications, CardiovascularTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, LeftBromocriptineassisted reproductive techniquebromocriptineperipartum cardiomyopathy

Identifiers

PMID30568125
PMCPMC6421160
OpenAlexW2904370661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.